icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Thu 25 Jun 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Government websites use the protocol. HTTPS for encryption and security.

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Registered with the Digital Government Authority under number:
20250831619
Suggestions

News

Media 2518
icon 2015-05-05

SFDA VP: Drug Clearance will be given to authorized agents and licensed stores only

The Vice President of SFDA Drug Sector, Dr. Ibrahim Al Jufali, confirmed that SFDA strategy adopts the best international practices of control to face...
More
Risk of hypersensitivity reactions of products containing ambroxol and bromhexine
icon 2014-07-07

Risk of hypersensitivity reactions of products containing ambroxol and bromhexine

The Saudi Food and Drug Authority would like to inform the healthcare professionals and the public that after reviewing the safety profile for...
More
Media 2516
icon 2013-02-26

Drug Sector Welcomes Al Majma’ah University Students

SFDA welcomed at its Head Office a student delegation from the faculty of Medicine & Pharmacology of Al Majma’ah University, on Tuesday 2/4/1434H. The...
More
Saudi Food and Drug Authority (SFDA) PRESS RELEASE- Safety of Diane 35® and Risk of Thromboembolism
icon 2013-02-11

Saudi Food and Drug Authority (SFDA) PRESS RELEASE- Safety of Diane 35® and Risk of Thromboembolism

The Saudi Food and Drug Authority (SFDA) would like to share some recent information regarding use of Diane 35® (cyproterone acetate 2 mg + ethinyl...
More
Measures to minimise the risk of developing nephrogenic systemic fibrosis with the use of gadolinium-containing contrast agents
icon 2013-02-10

Measures to minimise the risk of developing nephrogenic systemic fibrosis with the use of gadolinium-containing contrast agents

The European Committee for Medicinal Products for Human Use (CHMP) has reviewed the risk of nephrogenic systemic fibrosis (NSF) with gadolinium...
More
Media 2515
icon 2013-02-10

Rare Cases of Liver Injury Reported with Use of Orlistat (Xenical®)

Orlistat is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI) ≥ 30 kg/m2 and...
More